RTI Surgical Expands Portfolio of Spine Implants to Meet Surgeon Needs and Improve Patient Outcomes

RTI Surgical Expands Portfolio of Spine Implants to Meet Surgeon Needs and Improve Patient Outcomes (RTI Surgical)

UF startup and Sid Martin Biotech alum RTI Surgical, Inc. a global surgical implant company, announced the full commercial launch of its Fortilink®-TS and -L IBF Systems, adding to a growing series of interbody fusion devices featuring proprietary TETRAfuse® 3D Technology. The Fortilink-TS and -L Systems are intended for use in lumbar interbody fusion procedures at one or two adjoining levels in patients with degenerative disc disease. TETRAfuse 3D Technology is the first 3D printed polymer-based interbody fusion device to incorporate a nano-roughi surface that has demonstrated, in a pre-clinical study, more notable trabecular bone ingrowth compared to PEEK and titanium-coated PEEKii.

“The Fortilink-L System is the first osteointegrative, radiolucent cage,” said Joseph O’Brien, M.D., M.P.H., founder of the Washington Spine & Scoliosis Institute at OrthoBethesda in Bethesda, Maryland, and one of the first surgeons to implant the Fortilink-L device. “While other companies are focusing on titanium, TETRAfuse 3D Technology offers ingrowth features that help the implant to fully integrate with the fusing bone. It also has best-in-class X-ray compatibility, which allows me to track my patients’ progress with more confidence.”

Learn more about RTI Surgical Expands Portfolio of Spine Implants to Meet Surgeon Needs and Improve Patient Outcomes.

X